Literature DB >> 12799762

Proximal femoral reconstruction with custom mega prosthesis.

M Natarajan1, J C Bose, G Rajkumar.   

Abstract

Seventy-seven patients with proximal femoral tumours underwent limb salvage surgery with custom mega prostheses between July 1989 and January 2002. We describe 44 cases with a mean follow-up of 57.8 months. Forty-one patients presented with malignant neoplasms of which 11 were malignant giant cell tumours, eight were chondrosarcoma and five were metastases. Wide margins were achieved for all malignant tumours, and marginal resection was done for all benign and metastatic lesions. Six patients died of disease and two were lost to follow-up. Mechanical complications were observed in six cases, fracture being the most common. Oncological complications occurred in five patients. Functional activity was satisfactory in 79% of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12799762      PMCID: PMC3458442          DOI: 10.1007/s00264-003-0451-z

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  14 in total

1.  Long-term followup of proximal femoral allografts.

Authors:  Edward J Fox; Mohammad Anwar Hau; Mark C Gebhardt; Francis J Hornicek; William W Tomford; Henry J Mankin
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

2.  Modular megaprosthesis for proximal femoral tumors.

Authors:  I Ilyas; R Pant; A Kurar; P G Moreau; D A Younge
Journal:  Int Orthop       Date:  2002-03-08       Impact factor: 3.075

3.  Endoprosthetic replacement for primary malignant tumors of the proximal femur.

Authors:  Y Kabukcuoglu; R J Grimer; R M Tillman; S R Carter
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

4.  Megaprostheses in the treatment of primary malignant and metastatic tumors in the hip region.

Authors:  R P Veth; H K Nielsen; J Oldhoff; H Schraffordt Koops; D Mehta; J W Oosterhuis; W A Kamps; L N Göeken
Journal:  J Surg Oncol       Date:  1989-03       Impact factor: 3.454

5.  Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

Authors:  F Eilber; A Giuliano; J Eckardt; K Patterson; S Moseley; J Goodnight
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

6.  Reconstruction of hip stability after proximal and total femur resections.

Authors:  J Bickels; I Meller; R M Henshaw; M M Malawer
Journal:  Clin Orthop Relat Res       Date:  2000-06       Impact factor: 4.176

7.  Modular prosthetic replacement of the proximal femur after resection of a bone tumour a long-term follow-up.

Authors:  D Donati; M Zavatta; E Gozzi; S Giacomini; L Campanacci; M Mercuri
Journal:  J Bone Joint Surg Br       Date:  2001-11

8.  Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone.

Authors:  H J Mankin; S H Doppelt; T R Sullivan; W W Tomford
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

9.  A system of staging musculoskeletal neoplasms.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

10.  Reconstructions after resections of tumors involving the proximal femur.

Authors:  M E Johnson; H J Mankin
Journal:  Orthop Clin North Am       Date:  1991-01       Impact factor: 2.472

View more
  3 in total

1.  Lower limb salvage surgery: modular endoprosthesis in bone tumour treatment.

Authors:  D Orlic; M Smerdelj; R Kolundzic; M Bergovec
Journal:  Int Orthop       Date:  2006-08-08       Impact factor: 3.075

2.  Endoprosthetic reconstruction using total femoral custom mega prosthesis in malignant bone tumours.

Authors:  Mayil Vahanan Natarajan; Navin Balasubramanian; Viswanath Jayasankar; Mohammad Sameer
Journal:  Int Orthop       Date:  2009-03-04       Impact factor: 3.075

3.  Long-Term Outcome of Endoprosthetic Replacement for Proximal Femur Giant Cell Tumor.

Authors:  Gurinder Singh Gosal; Avneet Boparai; Gurpreet Singh Makkar
Journal:  Niger J Surg       Date:  2015 Jul-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.